
Cardinal Health (CAH) Stock Forecast & Price Target
Cardinal Health (CAH) Analyst Ratings
Bulls say
Cardinal Health is a strong player in the US pharmaceutical market, with a diversified portfolio and a strong presence in the healthcare supply chain. Their strategic investments and partnerships are expected to drive growth and margin expansion in the future. While there are risks in the industry such as changes in drug pricing and legal issues, the company's focus on long-term solutions and growth opportunities make it a favorable investment. Financially, Cardinal Health is projected to continue increasing revenue and earnings per share in the coming years through operational execution and strategic investments, showcasing their strong fundamentals and potential for long-term success.
Bears say
Cardinal Health is heavily reliant on a few large customers, which creates a risk of revenue loss or margin pressure. Their business segment that relies on international markets also introduces complexities and risks due to exposure to geopolitical and macroeconomic disruptions. We are also concerned about the potential impact of ongoing legal proceedings related to the distribution of controlled substances and the uncertainty around the durability and margin impact of the rapid growth of GLP-1 drugs on their business.
This aggregate rating is based on analysts' research of Cardinal Health and is not a guaranteed prediction by Public.com or investment advice.
Cardinal Health (CAH) Analyst Forecast & Price Prediction
Start investing in Cardinal Health (CAH)
Order type
Buy in
Order amount
Est. shares
0 shares